Thematic report: People who inject drugs - Monitoring Implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 Progress Report
This report is one in a series of thematic reports based on information submitted by reporting countries in 2012 on monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS.
Following ECDC’s 2010 progress report, the new series of thematic reports and evidence briefs present the main findings, discuss key issues, assess the progress made since 2010 and outlines areas for future actions in Europe’s response to HIV.
ECDC used information provided by countries in 2012 to produce a series of 10 reports covering key topics in the response to the HIV epidemic: leadership and resources, treatment care and support, stigma and discrimination; specifically affected groups like people who inject drugs, men who have sex with men, sex workers, migrants, prisoners and the role of civil society.
Among other things, the reports recommend that adequate and sustainable funding to maintain and expand prevention programmes for people who inject drugs and men who have sex with men be ensured. Implementation of HIV prevention services in prison settings may require that countries address legal and regulatory barriers.
Proficiency test for Listeria monocytogenes whole genome assembly 2018
16 May 2019 - This report presents the results of a proficiency test to evaluate the inter-laboratory reproducibility and portability of Listeria monocytogenes (Lm) genome assemblies in the EU/EEA.
ECDC strategic framework for the integration of molecular and genomic typing into European surveillance and multi-country outbreak investigations
4 Apr 2019 - This strategic framework document presents a proposed list of priority pathogens/diseases and outlines technical implementation options for the medium-term integration (2019–2021) of molecular/genomic typing information into EU-level surveillance and multi-country outbreak investigations.
Public consultation on HPV vaccines guidance opens
1 Apr 2019 - This guidance covers the following areas in relation to HPV vaccination: efficacy of the nine-valent HPV vaccine, HPV vaccination in people living with HIV and HPV vaccination in males and the cost-effectiveness of extending the HPV vaccination programme to include males.